Clark Street Value
Showing posts with label
AlloVir
.
Show all posts
Showing posts with label
AlloVir
.
Show all posts
Thursday, January 4, 2024
AlloVir: Another Broken Biotech
›
AlloVir (ALVR) (~$74MM market cap) is clinical-stage biotech focused on cell therapy to treat viral diseases. On 12/22/23, AlloVir paused th...
50 comments:
›
Home
View web version
